Key facts
- This page summarizes Andrew Sinclair's Form 4 filing for SOLENO THERAPEUTICS INC (SLNO).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 10 Jun 2024, 20:51.
Andrew Sinclair - 06 Jun 2024 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)
- Role
- Director
- Signature
- /s/ Anish Bhatnagar, Attorney-in-Fact
- Issuer symbol
- SLNO
- Transactions as of
- 06 Jun 2024
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 10 Jun 2024, 20:51:50 UTC
- Previous filing
- 07 Jun 2024
- Next filing
- 23 Aug 2024
- SEC
- View on sec.gov
Key filing fact
Andrew Sinclair filed Form 4 for SOLENO THERAPEUTICS INC (SLNO) on 10 Jun 2024.
Change
- Previous filing in this sequence was filed on 07 Jun 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
SLNO
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +6,500
- Change %
- Price
- $0.000000
- Shares after
- 6,500
- Date
- 06 Jun 2024
- Ownership
- Direct
- Footnotes
- F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs shall vest on the earlier of the twelve-month anniversary of June 6, 2024 or the day before the next annual stockholder meeting, subject to the Reporting Person continuing to be a Service Provider through such date. |